{"cluster": 36, "subcluster": 58, "abstract_summ": "Up to 20% of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) patients develop severe inflammatory complications with diffuse pulmonary inflammation, reflecting acute respiratory distress syndrome (ARDS).COVID-19 often manifests as only mild cold-like symptomatology, but severe disease with complications occurs in 15% of cases.A review of recent Severe acute respiratory syndrome-related coronavirus (SARS-CoV) and SARS-CoV-2 medical reports, as well as described characteristics of HP, lead us to postulate a theory for SARS-CoV-2 severe disease.The novel coronavirus disease 2019 (COVID-19) is an acute infectious disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).In this article, we discuss fresh perspectives and insights into the potential role of immune dysregulation in COVID-19 as well as similarities with systemic inflammatory response in sepsis and the rationale for exploring novel treatment options affecting host immune response.", "title_summ": "Managing Cutaneous Immune-Mediated Diseases During the COVID-19 PandemicBiochemical indicators of coronavirus disease 2019 exacerbation and the clinical implicationsIron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a reviewSevere COVID-19: A Review of Recent Progress With a Look Toward the FutureA Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation.The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?COVID-19 and Asthma: Reflection During the Pandemic.Targeting the NLRP3 Inflammasome in Severe COVID-19COVID-19 as an Acute Inflammatory Disease.", "title_abstract_phrases": "Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a reviewUp to 20% of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) patients develop severe inflammatory complications with diffuse pulmonary inflammation, reflecting acute respiratory distress syndrome (ARDS).A review of recent Severe acute respiratory syndrome-related coronavirus (SARS-CoV) and SARS-CoV-2 medical reports, as well as described characteristics of HP, lead us to postulate a theory for SARS-CoV-2 severe disease.COVID-19 often manifests as only mild cold-like symptomatology, but severe disease with complications occurs in 15% of cases.SARS-CoV-2 infection in severe cases involves the host response as an important contributor to the disease process and tissue damage, mainly due to dysregulated and excessive innate immune responses.This is the third acute infectious disease caused by coronavirus infection in this century, after sudden acute respirator syndrome and Middle East respiratory syndrome."}